• aTyr Pharma regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement, in a November 13, 2026, notice.
• Common stock closed at $1 or higher for 10 consecutive business days from October 30 through November 12, 2026.
• No Nasdaq deficiency notices remain outstanding as of the filing date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. aTyr Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001339970-26-000088), on November 13, 2026, and is solely responsible for the information contained therein.